Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-475 in Primary Hypercholesterolemia
NCT00143663Phase 3Completed
- Sponsor
- Takeda
- Start
- Sep 2005
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lapaquistat in hypercholesterolemia, sponsored by Takeda. Started Sep 2005; status: completed.
02
Drugs
lapaquistat
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00143663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00143663.